Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Abroad (travel likely)Recruiting

Conditions

Hepatitis B · Acute-On-Chronic Liver Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Liang Peng, Doctor) · pzp33@hotmail.com · +8613533978874

Study leads

Liang Peng, Doctor
Principal Investigator
Third Affiliated Hospital, Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

Chronic Hepatitis b

Abroad (travel likely)RecruitingPHASE1, PHASE2

Amsterdam, Netherlands

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Hepatitis B Virus (HBV) · Lung Transplant Recipient

Abroad (travel likely)RecruitingPHASE4

Toronto, Canada

Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia

Hepatitis B

Abroad (travel likely)Recruiting

Addis Ababa, Ethiopia

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

Hepatitis B Virus

Abroad (travel likely)Recruiting

Guangzhou, China